The defect engineering in graphene plays a significant role for the application of gas sensors. In this work, we proposed an efficient method to prepare ultrasensitive gas sensors based on the porous reduced graphene ...The defect engineering in graphene plays a significant role for the application of gas sensors. In this work, we proposed an efficient method to prepare ultrasensitive gas sensors based on the porous reduced graphene oxide(PRGO). Photo-Fenton etching was carried out on GO nanosheets in a controlled manner to enrich their vacancy defects. The resulting porous graphene oxide(PGO) was then drop-coated on interdigital electrodes and hydrothermal reduced at 180 °C. Controllable reduction was achieved by varying the water amount. The gas sensor based on PRGO-5 min-6h exhibited superior sensing and selective performance toward nitrogen dioxide(NO2), with an exceptional high sensitivity up to 12 ppm-1.The theoretical limit of detection is down to 0.66 ppb. The excellent performance could be mainly attributed to the typical vacancy defects of PRGO. Some residue carboxylic groups on the edges could also facilitate the adsorption of polar molecules. The process has a great potential for scalable fabrication of high-performance NO2gas sensors.展开更多
Background and purpose The role of depression in the development and outcome of cardiometabolic diseases remains to be clarified.We aimed to examine the extent to which depressive symptoms affect the transitions from ...Background and purpose The role of depression in the development and outcome of cardiometabolic diseases remains to be clarified.We aimed to examine the extent to which depressive symptoms affect the transitions from healthy to diabetes,stroke,heart disease and subsequent all-cause mortality in a middle-aged and elderly European population.Methods A total of 78212 individuals aged≥50 years from the Survey of Health Ageing and Retirement in Europe were included.Participants with any baseline cardiometabolic diseases including diabetes,stroke and heart disease were excluded.Depressive symptoms were measured by the Euro-Depression scale at baseline.Participants were followed up to determine the occurrence of cardiometabolic diseases and all-cause mortality.We used multistate models to estimate the transition-specific HRs and 95%CIs after adjustment of confounders.Results During 500711 person-years of follow-up,4742 participants developed diabetes,2173 had stroke,5487 developed heart disease and 7182 died.Depressive symptoms were significantly associated with transitions from healthy to diabetes(HR:1.12,95%CI:1.05 to 1.20),stroke(HR:1.31,95%CI:1.18 to 1.44),heart disease(HR:1.26,95%CI:1.18 to 1.34)and all-cause mortality(HR:1.41,95%CI:1.34 to 1.49).After cardiometabolic diseases,depressive symptoms were associated with the increased risk of all-cause mortality in patients with diabetes(HR:1.54,95%CI:1.25 to 1.89),patients who had stroke(HR:1.29,95%CI:1.03 to 1.61)and patients with heart disease(HR:1.21,95%CI:1.02 to 1.44).Conclusions Depressive symptoms increase the risk of diabetes,stroke and heart disease,and affect the risk of mortality after the onset of these cardiometabolic conditions.Screening and treatment of depressive symptoms may have profound implications for the prevention and prognosis of cardiometabolic diseases.展开更多
基金financially supported by National Natural Science Foundation of China (No. 52073302)。
文摘The defect engineering in graphene plays a significant role for the application of gas sensors. In this work, we proposed an efficient method to prepare ultrasensitive gas sensors based on the porous reduced graphene oxide(PRGO). Photo-Fenton etching was carried out on GO nanosheets in a controlled manner to enrich their vacancy defects. The resulting porous graphene oxide(PGO) was then drop-coated on interdigital electrodes and hydrothermal reduced at 180 °C. Controllable reduction was achieved by varying the water amount. The gas sensor based on PRGO-5 min-6h exhibited superior sensing and selective performance toward nitrogen dioxide(NO2), with an exceptional high sensitivity up to 12 ppm-1.The theoretical limit of detection is down to 0.66 ppb. The excellent performance could be mainly attributed to the typical vacancy defects of PRGO. Some residue carboxylic groups on the edges could also facilitate the adsorption of polar molecules. The process has a great potential for scalable fabrication of high-performance NO2gas sensors.
基金The development of the Harmonized SHARE was funded by the National Institute on Aging(R01 AG030153,RC2 AG036619,R03 AG043052)This work was supported by National Natural Science Foundation of China(81703316)+1 种基金Natural Science Foundation of Jiangsu Province(BK20170350)a project Funded by Priority Academic Program Development of Jiangsu Higher Education Institutions(PAPD)and Natural Science Research Projects of Colleges and Universities in Jiangsu Province(20KJB330004).
文摘Background and purpose The role of depression in the development and outcome of cardiometabolic diseases remains to be clarified.We aimed to examine the extent to which depressive symptoms affect the transitions from healthy to diabetes,stroke,heart disease and subsequent all-cause mortality in a middle-aged and elderly European population.Methods A total of 78212 individuals aged≥50 years from the Survey of Health Ageing and Retirement in Europe were included.Participants with any baseline cardiometabolic diseases including diabetes,stroke and heart disease were excluded.Depressive symptoms were measured by the Euro-Depression scale at baseline.Participants were followed up to determine the occurrence of cardiometabolic diseases and all-cause mortality.We used multistate models to estimate the transition-specific HRs and 95%CIs after adjustment of confounders.Results During 500711 person-years of follow-up,4742 participants developed diabetes,2173 had stroke,5487 developed heart disease and 7182 died.Depressive symptoms were significantly associated with transitions from healthy to diabetes(HR:1.12,95%CI:1.05 to 1.20),stroke(HR:1.31,95%CI:1.18 to 1.44),heart disease(HR:1.26,95%CI:1.18 to 1.34)and all-cause mortality(HR:1.41,95%CI:1.34 to 1.49).After cardiometabolic diseases,depressive symptoms were associated with the increased risk of all-cause mortality in patients with diabetes(HR:1.54,95%CI:1.25 to 1.89),patients who had stroke(HR:1.29,95%CI:1.03 to 1.61)and patients with heart disease(HR:1.21,95%CI:1.02 to 1.44).Conclusions Depressive symptoms increase the risk of diabetes,stroke and heart disease,and affect the risk of mortality after the onset of these cardiometabolic conditions.Screening and treatment of depressive symptoms may have profound implications for the prevention and prognosis of cardiometabolic diseases.
